Article
TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation-group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy.
The Journal of clinical investigation - 17 Nov 2025
Nakazawa Yuka, Ye Lin, Oka Yasuyoshi, Morinaga Hironobu, Kato Kana, Shimada Mayuko, Tsukada Kotaro, Tsujikawa Koyo, Nishio Yosuke, Fassihi Hiva, Mohammed Shehla, Lehmann Alan R, Ogi Tomoo
Abstract excerpt
Few drugs are available for rare diseases due to economic disincentives. However, tailored medications for extremely rare disorders (N-of-1) offer a ray of hope. Artificial antisense oligonucleotides (ASOs) are now best known for their use in spinal muscular atrophy (SMA). The success of nusinersen/Spinraza for SMA indicates the potential of ASO therapies for other rare conditions. We propose a strategy to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
